LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,545 | -2.7% | 23 | 0.0% | 0.00% | – |
| Q2 2023 | $1,588 | +43.1% | 23 | 0.0% | 0.00% | – |
| Q1 2023 | $1,110 | +71.0% | 23 | +76.9% | 0.00% | – |
| Q4 2022 | $649 | – | 13 | +62.5% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 8 | -96.3% | 0.00% | -100.0% |
| Q4 2021 | $10,000 | -28.6% | 214 | -23.6% | 0.00% | -50.0% |
| Q3 2021 | $14,000 | +27.3% | 280 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $11,000 | +37.5% | 280 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $8,000 | +33.3% | 280 | +40.0% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |